Shanghai, China, July 6, 2021 — GREAF Biotech, the global supplier of responsibly sourced, plant-derived novel active ingredients, announced it has entered a contractual agreement with LBB Specialties (LBBS), a leader in North American specialty chemicals and ingredients distribution. The agreement indicates a strategic step for GREAF into the U.S. market of active ingredients, and it is also a landmark for GREAF to be deeply involved in the international market.
LBB Specialties through its subsidiary companies is a leader in the North American specialty chemical and ingredients distribution industry. LBBS provides a source of distinct advantages to the industry through the carefully selected product portfolios, market expertise, and their commercially strategic and operationally sound practices.
Since 2010, GREAF is oriented to be at the forefront of the market by developing and manufacturing high-quality cosmetic active ingredients, herbal extracts and fermentative ingredients in steps of global novel biotechnology. With this agreement, we are convinced that we have reached a milestone in our company, and we are more confident of being leading in the cosmetic industry worldwide. Having the full support of LBBS and their expertise for this new stage is a guarantee that we will support our future clients in the best possible way.
Post time: Jul-06-2021